Public and political controversy over the management of medical supplies and drugs by the Government of Guyana is not confined to what its critics allege is considerable discrimination in favour of the privately-owned New Guyana Pharmaceutical Corporation (New GPC).
It also extends to concerns over proper accounting for, storage and timely use
